[8-K] Femasys Inc. Reports Material Event
Femasys Inc. reported in a Current Report on Form 8-K that on August 20, 2025 it issued a press release announcing that the company has secured UK regulatory approval for FemBloc Permanent Birth Control. The filing states the press release is furnished as Exhibit 99.1 and is incorporated by reference into the report. The 8-K does not include further operational, commercial or financial details within the filing text provided.
Femasys Inc. ha comunicato, in un Current Report sul Modulo 8-K, che in data 20 agosto 2025 ha diffuso un comunicato stampa in cui annuncia di aver ottenuto l'approvazione regolatoria nel Regno Unito per FemBloc Permanent Birth Control. Nel documento 猫 indicato che il comunicato 猫 fornito come Allegato 99.1 e viene incorporato per riferimento nel rapporto. Il filing non contiene ulteriori dettagli operativi, commerciali o finanziari nel testo reso disponibile.
Femasys Inc. inform贸 en un Current Report en el Formulario 8-K que el 20 de agosto de 2025 emiti贸 un comunicado de prensa anunciando que la compa帽铆a obtuvo la aprobaci贸n regulatoria en el Reino Unido para FemBloc Permanent Birth Control. El informe se帽ala que el comunicado se presenta como Exhibici贸n 99.1 y se incorpora por referencia al reporte. El 8-K no aporta m谩s detalles operativos, comerciales ni financieros en el texto incluido.
Femasys Inc.電� Form 8-K 順勳灛氤搓碃靹滌棎靹� 2025雲� 8鞗� 20鞚�鞐� 氤措弰鞛愲毳� 韱淀暣 須岇偓臧� 鞓侁淡鞐愳劀 FemBloc Permanent Birth Control鞚� 攴滌牅 鞀轨澑鞚� 氚涭晿鞚岇潉 氚滍憸頄堧嫟瓿� 氤搓碃頄堨姷雼堧嫟. 氤搓碃靹滌棎電� 頃措嫻 氤措弰鞛愲臧� 歃濍箼鞛愲 99.1(Exhibit 99.1)搿� 鞝滉车霅橂┌ 氤搓碃靹滌棎 彀胳“搿� 韽暔霅滊嫟瓿� 氇呾嫓霅橃柎 鞛堨姷雼堧嫟. 氤� 8-K 鞝滌稖氍胳棎電� 鞝滉车霅� 氤鸽 雮挫棎靹� 於旉皜鞝侅澑 鞖挫榿靸伮缝儊鞐呾爜路鞛鞝� 靹鸽秬靷暛鞚� 韽暔霅橃 鞎婌晿鞀惦媹雼�.
Femasys Inc. a indiqu茅 dans un Current Report sur le Formulaire 8鈥慘 que le 20 ao没t 2025 elle a publi茅 un communiqu茅 de presse annon莽ant que la soci茅t茅 a obtenu l'approbation r茅glementaire au Royaume鈥慤ni pour FemBloc Permanent Birth Control. Le d茅p么t pr茅cise que le communiqu茅 est fourni en tant que Exhibit 99.1 et est int茅gr茅 par renvoi au rapport. Le 8鈥慘 ne contient pas d'autres 茅l茅ments op茅rationnels, commerciaux ou financiers dans le texte fourni.
Femasys Inc. gab in einem Current Report auf Formular 8-K bekannt, dass das Unternehmen am 20. August 2025 eine Pressemitteilung ver枚ffentlicht hat, in der es die regulatorische Zulassung im Vereinigten K枚nigreich f眉r FemBloc Permanent Birth Control meldet. In der Einreichung hei脽t es, die Pressemitteilung werde als Anlage 99.1 eingereicht und sei durch Verweis in den Bericht aufgenommen. Der 8-K enth盲lt im vorgelegten Text keine weiteren operativen, kommerziellen oder finanziellen Angaben.
- UK regulatory approval announced for FemBloc Permanent Birth Control
- Press release furnished as Exhibit 99.1, making the announcement formally part of the 8-K
- Filing contains no operational, commercial, or financial details about the approval or next steps
- No approval documentation or timelines are included in the 8-K text; readers must consult Exhibit 99.1
Insights
TL;DR: The company confirms UK regulatory approval of FemBloc and furnishes a press release as Exhibit 99.1.
The filing explicitly states that Femasys secured regulatory approval in the United Kingdom for its FemBloc permanent birth control product and that the company issued a press release on August 20, 2025 which is attached as Exhibit 99.1. The report contains no additional regulatory documentation, approval letters, or technical details in the 8-K text itself; readers must refer to the referenced press release (Exhibit 99.1) for substantive information.
TL;DR: Material regulatory milestone announced, but the filing includes no financial or commercial detail to assess investor impact.
The Form 8-K confirms a material event鈥攁 UK regulatory approval announcement鈥攂ut provides only a statement that a press release was furnished as Exhibit 99.1. The filing does not present revenue projections, commercialization plans, timing, or financial statements tied to the approval. As a result, the announcement is potentially important but the 8-K itself lacks the financial and operational data needed to quantify investor impact.
Femasys Inc. ha comunicato, in un Current Report sul Modulo 8-K, che in data 20 agosto 2025 ha diffuso un comunicato stampa in cui annuncia di aver ottenuto l'approvazione regolatoria nel Regno Unito per FemBloc Permanent Birth Control. Nel documento 猫 indicato che il comunicato 猫 fornito come Allegato 99.1 e viene incorporato per riferimento nel rapporto. Il filing non contiene ulteriori dettagli operativi, commerciali o finanziari nel testo reso disponibile.
Femasys Inc. inform贸 en un Current Report en el Formulario 8-K que el 20 de agosto de 2025 emiti贸 un comunicado de prensa anunciando que la compa帽铆a obtuvo la aprobaci贸n regulatoria en el Reino Unido para FemBloc Permanent Birth Control. El informe se帽ala que el comunicado se presenta como Exhibici贸n 99.1 y se incorpora por referencia al reporte. El 8-K no aporta m谩s detalles operativos, comerciales ni financieros en el texto incluido.
Femasys Inc.電� Form 8-K 順勳灛氤搓碃靹滌棎靹� 2025雲� 8鞗� 20鞚�鞐� 氤措弰鞛愲毳� 韱淀暣 須岇偓臧� 鞓侁淡鞐愳劀 FemBloc Permanent Birth Control鞚� 攴滌牅 鞀轨澑鞚� 氚涭晿鞚岇潉 氚滍憸頄堧嫟瓿� 氤搓碃頄堨姷雼堧嫟. 氤搓碃靹滌棎電� 頃措嫻 氤措弰鞛愲臧� 歃濍箼鞛愲 99.1(Exhibit 99.1)搿� 鞝滉车霅橂┌ 氤搓碃靹滌棎 彀胳“搿� 韽暔霅滊嫟瓿� 氇呾嫓霅橃柎 鞛堨姷雼堧嫟. 氤� 8-K 鞝滌稖氍胳棎電� 鞝滉车霅� 氤鸽 雮挫棎靹� 於旉皜鞝侅澑 鞖挫榿靸伮缝儊鞐呾爜路鞛鞝� 靹鸽秬靷暛鞚� 韽暔霅橃 鞎婌晿鞀惦媹雼�.
Femasys Inc. a indiqu茅 dans un Current Report sur le Formulaire 8鈥慘 que le 20 ao没t 2025 elle a publi茅 un communiqu茅 de presse annon莽ant que la soci茅t茅 a obtenu l'approbation r茅glementaire au Royaume鈥慤ni pour FemBloc Permanent Birth Control. Le d茅p么t pr茅cise que le communiqu茅 est fourni en tant que Exhibit 99.1 et est int茅gr茅 par renvoi au rapport. Le 8鈥慘 ne contient pas d'autres 茅l茅ments op茅rationnels, commerciaux ou financiers dans le texte fourni.
Femasys Inc. gab in einem Current Report auf Formular 8-K bekannt, dass das Unternehmen am 20. August 2025 eine Pressemitteilung ver枚ffentlicht hat, in der es die regulatorische Zulassung im Vereinigten K枚nigreich f眉r FemBloc Permanent Birth Control meldet. In der Einreichung hei脽t es, die Pressemitteilung werde als Anlage 99.1 eingereicht und sei durch Verweis in den Bericht aufgenommen. Der 8-K enth盲lt im vorgelegten Text keine weiteren operativen, kommerziellen oder finanziellen Angaben.
FAQ
When did Femasys (FEMY) report the regulatory approval?
What product received UK regulatory approval according to the filing?
Where can I find the full details of the approval announced by Femasys?
Does the 8-K include financial impact or commercialization plans for FemBloc?
What is Femasys's ticker symbol as referenced in the filing?
